Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient

NCT00002025 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Infections
Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Ganciclovir

Sponsor

Hoffmann-La Roche